Rapid genetic diagnosis with the TRC (transcription-reverse transcription concerted reaction) system for cancer micrometastasis^1

利用TRC(转录-逆转录协同反应)系统对癌症微转移进行快速基因诊断^1

基本信息

  • 批准号:
    16591310
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2005
  • 项目状态:
    已结题

项目摘要

Detection of cancer micrometastases that are missed by conventional cytological and histopathological examination is required for improvement of cancer therapy. The aim of this study was to establish a rapid and practical genetic assay to detect micrometastasis in gastric cancer and to assess its clinical significance with respect to prognosis.A novel RNA amplification system with TRC reaction (transcription-reverse transcription concerted reaction) was introduced for quantitative detection of CEA (carcinoembryonic antigen) mRNA, which is widely used as a molecular marker for cancer micrometastasis. Peritoneal lavage fluid specimens and lymph nodes collected from cancer surgery were subjected to the assay, and the clinical significance of the results in prediction of recurrence and survival was examined.The quantification, sensitivity, and reproducibility of the assay using the TRC reaction were equal to those of quantitative RT-PCR with LightCycler^<TM>. The most important advantage of the assay was its simplicity and rapidity. Molecular diagnosis of peritoneal lavage fluid by the TRC reaction significantly correlated with depth of invasion, peritoneal metastasis, clinical stage, overall survival and peritoneal recurrence-free survival.Molecular diagnosis of peritoneal lavage fluid with the TRC reaction could be a useful prognostic indicator for peritoneal recurrence and survival. Because the TRC reaction is more rapid and simple than RT-PCR as a format for detecting RNA sequences, it may enhance the genetic diagnosis of cancer micrometastasis and may contribute to cancer therapy.
传统的细胞学和组织病理学检查遗漏的癌症微转移的检测是改善癌症治疗所必需的。为建立一种快速、实用的胃癌微转移基因检测方法,并探讨其临床意义,本研究采用一种新的RNA扩增技术结合转录-逆转录协同反应(transcription-reverse transcriptionconcerted reaction,TRC),对胃癌微转移标志物癌胚抗原(carcinoembryonic antigen,CEA)mRNA进行定量检测。对肿瘤手术中收集的腹腔灌洗液和淋巴结标本进行检测,并对检测结果在预测复发和生存方面的临床意义进行了检验<TM>。该方法最重要的优点是简便、快速。TRC反应对腹腔灌洗液的分子诊断与浸润深度、腹膜转移、临床分期、总生存率和无腹膜复发生存率显著相关,TRC反应对腹腔灌洗液的分子诊断可能是预测腹膜复发和生存的一个有用指标。由于TRC反应作为检测RNA序列的形式比RT-PCR更快速和简单,因此它可以增强癌症微转移的基因诊断,并可能有助于癌症治疗。

项目成果

期刊论文数量(36)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Rapid genetic diagnosis with the transcription-reverse transcription concerted reaction system for cancer micrometastasis
  • DOI:
    10.1245/aso.2004.12.043
  • 发表时间:
    2004-08-01
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Ishii, T;Fujiwara, Y;Monden, M
  • 通讯作者:
    Monden, M
Clinical value of alterations in p73 gene, related to p53 at 1p36, in human hepatocellular carcinoma.
  • DOI:
    10.3892/ijo.24.2.441
  • 发表时间:
    2004-02
  • 期刊:
  • 影响因子:
    5.2
  • 作者:
    T. Aoki;A. Miyamoto;S. Marubashi;H. Nagano;K. Umeshita;Y. Fujiwara;K. Dono;S. Nakamori;M. Sakon;M. Monden
  • 通讯作者:
    T. Aoki;A. Miyamoto;S. Marubashi;H. Nagano;K. Umeshita;Y. Fujiwara;K. Dono;S. Nakamori;M. Sakon;M. Monden
微小転移診断の外科臨床応用
微转移诊断的外科临床应用
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    藤原義之;他
  • 通讯作者:
Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma
  • DOI:
    10.1158/1078-0432.ccr-0723-03
  • 发表时间:
    2004-08-15
  • 期刊:
  • 影响因子:
    11.5
  • 作者:
    Yamamoto, S;Tomita, Y;Aozasa, K
  • 通讯作者:
    Aozasa, K
I. 診断 腹膜播種の腹腔鏡診断
一、诊断腹腔镜诊断腹膜播散
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    藤原義之;他
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FUJIWARA Yoshiyuki其他文献

FUJIWARA Yoshiyuki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FUJIWARA Yoshiyuki', 18)}}的其他基金

Molecular mechanism in early establishment of peritoneal metastasis from gastric cancer.
胃癌腹膜转移早期形成的分子机制。
  • 批准号:
    17K10588
  • 财政年份:
    2017
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel molecular targeted therapy for peritoneal dissemination of gastric cancer
胃癌腹膜播散的新型分子靶向治疗
  • 批准号:
    18591463
  • 财政年份:
    2006
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of a new multidisciplinary therapy with pre-operative laparoscopy and molecular diagnosis for peritoneal dissemination of advanced gastric cancer.
建立一种新的多学科治疗方法,包括术前腹腔镜检查和分子诊断,治疗晚期胃癌的腹膜播散。
  • 批准号:
    14571194
  • 财政年份:
    2002
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of new strategy in surgical oncology introduced with regulation of micometastasis
开发微转移调控的肿瘤外科新策略
  • 批准号:
    12671156
  • 财政年份:
    2000
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Roles of Glial Autophagy in Breast Cancer Brain Metastasis
胶质细胞自噬在乳腺癌脑转移中的作用
  • 批准号:
    10660141
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Project 1: Combining PARP inhibition with radiation to sensitize HR proficient pancreatic cancers to immunotherapy
项目 1:将 PARP 抑制与放射治疗相结合,使 HR 熟练的胰腺癌对免疫治疗敏感
  • 批准号:
    10554472
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
In vivo Evaluation of Lymph Nodes Using Quantitative Ultrasound
使用定量超声对淋巴结进行体内评估
  • 批准号:
    10737152
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Multiplex Ultrasound Imaging for the Detection of Head and Neck Lymph Node Micrometastases
用于检测头颈部淋巴结微转移的多重超声成像
  • 批准号:
    10870266
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Drug combination nanoparticles for advanced treatment of metastatic TNBC
用于晚期治疗转移性 TNBC 的药物组合纳米颗粒
  • 批准号:
    10648912
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
A Novel Postoperative Prognostic Liquid Biopsy: Tumor-Associated cfDNA and Leukocyte Analysis in Oropharyngeal Cancer Surgical Drain Fluid
一种新型术后预后液体活检:口咽癌手术引流液中肿瘤相关 cfDNA 和白细胞分析
  • 批准号:
    10678080
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Modulation of Epigenetic Target in the Bone to Treat Breast Cancer Metastasis
调节骨中的表观遗传靶标来治疗乳腺癌转移
  • 批准号:
    10736034
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Engineered Nanoformulation for Immune-modulation in Cancer
用于癌症免疫调节的工程纳米制剂
  • 批准号:
    10719487
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Next Gen Targeted nanoparticles for Inhibiting Gli2 in Bone Metastatic Tumors
用于抑制骨转移肿瘤中 Gli2 的下一代靶向纳米颗粒
  • 批准号:
    10623705
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
The Role of Endothelial ACKR1 in Triple-Negative Breast Cancer Metastasis
内皮细胞 ACKR1 在三阴性乳腺癌转移中的作用
  • 批准号:
    10604865
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了